CliffBio

Cumberland

Patent cliffs & loss of exclusivity

Cumberland is a specialized cryptoasset trading company within DRW, a diversified principal trading firm with more than 25 years of experience in markets around the world.

Company

Legal NameCumberland DRW LLC
Company Operating StatusActive
Full Address540 W Madison St, Chicago, Illinois 60661, US
LinkedIn URLhttps://www.linkedin.com/company/cumberland-drw/about/
Twitter URLhttps://twitter.com/CumberlandSays
Official Websitehttps://www.cumberland.io/

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. CALDOLORIBUPROFENSmall mol.May 2026
  2. VIBATIVTELAVANCIN HYDROCHLORIDESmall mol.Jan 2027
  3. VIBATIVTELAVANCIN HYDROCHLORIDESmall mol.Jan 2027
  4. CALDOLORIBUPROFENSmall mol.Mar 2032
  5. CALDOLORIBUPROFENSmall mol.Mar 2032
  6. ACETADOTEACETYLCYSTEINESmall mol.Apr 2032
  7. OMECLAMOX-PAKAMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLESmall mol.—
  8. SANCUSOGRANISETRONSmall mol.—
  9. LACTULOSELACTULOSESmall mol.—
  10. LACTULOSELACTULOSESmall mol.—
  11. VAPRISOLCONIVAPTAN HYDROCHLORIDESmall mol.—
  12. VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINERCONIVAPTAN HYDROCHLORIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Cumberland — patent cliffs & loss of exclusivity | CliffBio